Jennifer L. McNeer to Adolescent
This is a "connection" page, showing publications Jennifer L. McNeer has written about Adolescent.
Connection Strength
0.663
-
Adding induction intrathecal cytarabine in newly diagnosed CNS2 B-acute lymphoblastic leukemia does not improve outcomes. Blood Adv. 2026 06 23; 10(12):4184-4192.
Score: 0.095
-
How the COG is Approaching the High-Risk Patient with ALL: Incorporation of Immunotherapy into Frontline Treatment. Clin Lymphoma Myeloma Leuk. 2020 09; 20 Suppl 1:S8-S11.
Score: 0.064
-
Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults. Pediatr Blood Cancer. 2018 06; 65(6):e26989.
Score: 0.053
-
Pediatric Hematology, Oncology, and Stem Cell Transplantation. Pediatr Ann. 2015 Jul; 44(7):278-9.
Score: 0.044
-
Acute lymphoblastic leukemia in young adults: which treatment? Curr Opin Oncol. 2012 Sep; 24(5):487-94.
Score: 0.037
-
The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers. Br J Haematol. 2010 Jun; 149(5):638-52.
Score: 0.031
-
Early elevation of C-reactive protein correlates with severe infection and nonrelapse mortality in children undergoing allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2010 Mar; 16(3):350-7.
Score: 0.031
-
Toxicity from asparaginase during acute lymphoblastic leukemia induction: a report from the Children's Oncology Group. Blood Adv. 2026 07 28; 10(14):4923-4930.
Score: 0.024
-
American Society of Hematology 2026 guidelines for frontline management of acute lymphoblastic leukemia in adolescents and young adults. Blood Adv. 2026 Jul 14; 10(13):4671-4708.
Score: 0.024
-
Blinatumomab Utilization in Pediatric B-Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West. Pediatr Blood Cancer. 2026 Jul; 73(7):e70383.
Score: 0.024
-
The challenge of deintensifying chemotherapy for children and adolescents with B-ALL in the immunotherapy era. Hematology Am Soc Hematol Educ Program. 2025 12 05; 2025(1):229-235.
Score: 0.023
-
Feasibility of Symptom Burden Assessments and Early Palliative Care Integration in an Adolescent and Young Adult Leukemia Clinic. J Adolesc Young Adult Oncol. 2026 Oct; 15(5):378-383.
Score: 0.023
-
Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination. J Natl Cancer Inst. 2025 Sep 01; 117(9):1764-1773.
Score: 0.022
-
Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2022 11; 69(11):e29937.
Score: 0.018
-
Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia. Cancer Med. 2021 11; 10(21):7551-7560.
Score: 0.017
-
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia. Blood Adv. 2021 01 26; 5(2):504-512.
Score: 0.016
-
Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study. Lancet Oncol. 2020 03; 21(3):421-435.
Score: 0.015
-
Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial. J Clin Oncol. 2019 08 10; 37(23):2072-2081.
Score: 0.015
-
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Leukemia. 2019 04; 33(4):884-892.
Score: 0.014
-
Patient-Reported Health-Related Quality-of-Life Assessment at the Point-of-Care with Adolescents and Young Adults with Cancer. J Adolesc Young Adult Oncol. 2018 02; 7(1):97-102.
Score: 0.013
-
Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis. Cancer. 2018 01 01; 124(1):136-144.
Score: 0.013
-
Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL). Leuk Lymphoma. 2017 04; 58(4):950-958.
Score: 0.012
-
Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study. Cancer. 2017 Jan 01; 123(1):122-130.
Score: 0.012
-
Repeated Blood Cultures in Pediatric Febrile Neutropenia: Would Following the Guidelines Alter the Outcome? Pediatr Blood Cancer. 2016 07; 63(7):1244-9.
Score: 0.012
-
Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorship. Cancer. 2016 Mar 15; 122(6):954-61.
Score: 0.012